{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T05:02:00Z","timestamp":1789794120371,"version":"4.0.1"},"reference-count":14,"publisher":"The Japan Geriatrics Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nippon Ronen Igakkai Zasshi","Nihon Ronen Igakkai Zasshi","Jpn J Geriat","Jpn. j. geriat"],"published-print":{"date-parts":[[2026,7,25]]},"DOI":"10.3143\/geriatrics.63.237","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:12:57Z","timestamp":1789423977000},"page":"237-242","source":"Crossref","is-referenced-by-count":0,"title":["An elderly patient with type 2 diabetes who developed a hyperglycemic emergency and showed a marked decline in insulin secretion, but she was able to be weaned off insulin by alleviating glucose toxicity and adjusting her medication: A case report","\u9ad8\u8840\u7cd6\u7dca\u6025\u75c7\u3092\u767a\u75c7\u3057\u30a4\u30f3\u30b9\u30ea\u30f3\u5206\u6ccc\u80fd\u304c\u8457\u660e\u306b\u4f4e\u4e0b\u3057\u3066\u3044\u305f\u3082\u306e\u306e\u7cd6\u6bd2\u6027\u89e3\u9664\u3068\u85ac\u5264\u8abf\u6574\u306b\u3088\u308a\u30a4\u30f3\u30b9\u30ea\u30f3\u3092\u96e2\u8131\u3057\u5f97\u305f\u9ad8\u9f622\u578b\u7cd6\u5c3f\u75c5\u306e1\u4f8b"],"prefix":"10.3143","volume":"63","author":[{"given":"Yumi","family":"Ohashi","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Kumagai","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Hiraga","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Maezawa","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hematology and Gerontology, Graduate School of Medicine, Chiba University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1704","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"2) \u4e09\u5bb6\u767b\u559c\u592b, \u91cc\u795e\u6c38\u4e00, \u66fd\u548c\u4eae\u4e00, \u6817\u5c71\u8302\u53f8, \u5ca1\u4e95\u4e00\u5f66, \u68ee\u7530 \u4e00\u307b\u304b: \u7cd6\u5c3f\u75c5\u60a3\u8005\u306b\u304a\u3051\u308bInsulin\u4f9d\u5b58\u5ea6\u306e\u8a55\u4fa1-Glucagon\u9759\u6ce8\u8ca0\u8377\u6642\u306e\u8840\u6f3fCPR\u53cd\u5fdc\u3088\u308a-. \u7cd6\u5c3f\u75c5 1985; 28: 713-719.","DOI":"10.11213\/tonyobyo1958.28.713"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3) Madsbad S, Krarup T, McNair P, Christiansen C, Faber OK, Transb\u00f8l I, et al.: Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand 1981; 210: 153-156.","DOI":"10.1111\/j.0954-6820.1981.tb09793.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"5) Uehara R, Yamada E, Nakajima Y, Osaki A, Okada S, Yamada M: Casual C peptide index: Predicting the subsequent need for insulin therapy in outpatients with type 2 diabetes under primary care. J Diabetes 2022; 14: 221-227.","DOI":"10.1111\/1753-0407.13257"},{"key":"4","unstructured":"6) \u65e5\u672c\u7cd6\u5c3f\u75c5\u5b66\u4f1a: \u7cd6\u5c3f\u75c5\u306b\u304a\u3051\u308b\u6025\u6027\u4ee3\u8b1d\u5931\u8abf\u30fb\u30b7\u30c3\u30af\u30c7\u30a4 (\u611f\u67d3\u75c7\u3092\u542b\u3080). \u7cd6\u5c3f\u75c5\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f32024 (\u65e5\u672c\u7cd6\u5c3f\u75c5\u5b66\u4f1a\u7de8), \u5357\u6c5f\u5802, \u6771\u4eac, 2024, p455."},{"key":"5","doi-asserted-by":"publisher","unstructured":"7) Rossetti L, Giaccari A, DeFronzo RA: Glucose toxicity. Diabetes Care 1990; 13: 610-630.","DOI":"10.2337\/diacare.13.6.610"},{"key":"6","doi-asserted-by":"publisher","unstructured":"8) Li Y, Xu W, Liao Z, Yao B, Chen X, Huang Z, et al.: Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care 2004; 27: 2597-2602.","DOI":"10.2337\/diacare.27.11.2597"},{"key":"7","doi-asserted-by":"publisher","unstructured":"9) Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D, et al.: Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet 2008; 371: 1753-1760.","DOI":"10.1016\/S0140-6736(08)60762-X"},{"key":"8","doi-asserted-by":"crossref","unstructured":"10) Retnakaran R, Pu J, Ye C, Emery A, Harris SB, Reichert SM, et al.: A Glycemic Threshold Above Which the Improvement of \u03b2-Cell Function and Glycemia in Response to Insulin Therapy Is Amplified in Early Type 2 Diabetes: The Reversal of Glucotoxicity. Diabetes Care 2024; 47: 2017-2023.","DOI":"10.2337\/dc24-1375"},{"key":"9","doi-asserted-by":"crossref","unstructured":"11) Inoue M, Shiramoto M, Oura T, Nasu R, Nakano M, Takeuchi M: Effect of Once-Weekly Dulaglutide on Glucose Levels in Japanese Patients with Type 2 Diabetes: Findings from a Phase 4, Randomized Controlled Trial. Diabetes Ther 2019; 10: 1019-1027.","DOI":"10.1007\/s13300-019-0605-7"},{"key":"10","doi-asserted-by":"crossref","unstructured":"12) Chin R, Nagaoka S, Nakasawa H, Tanaka Y, Inagaki N: Safety and effectiveness of dulaglutide 0.75 mg in Japanese patients with type 2 diabetes in real-world clinical practice: 36 month post-marketing observational study. J Diabetes Investig 2023; 14: 247-258.","DOI":"10.1111\/jdi.13932"},{"key":"11","doi-asserted-by":"crossref","unstructured":"13) Onishi Y, Oura T, Nishiyama H, Ohyama S, Takeuchi M, Iwamoto N: Subgroup analysis of phase 3 studies of dulaglutide in Japanese patients with type 2 diabetes. Endocr J 2016; 63: 263-273.","DOI":"10.1507\/endocrj.EJ15-0518"},{"key":"12","doi-asserted-by":"crossref","unstructured":"14) Holst JJ: The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87: 1409-1439.","DOI":"10.1152\/physrev.00034.2006"},{"key":"13","doi-asserted-by":"publisher","unstructured":"15) Baggio LL, Drucker DJ: Biology of incretins: GLP-1 and GIP. Gastroenterology 2007; 132: 2131-2157.","DOI":"10.1053\/j.gastro.2007.03.054"},{"key":"14","unstructured":"16) \u5c0f\u8c37\u91ce\u8087: \u9ad8\u9f62\u8005\u65bd\u8a2d\u7b49\u3067\u306e\u30a4\u30f3\u30b9\u30ea\u30f3\u7642\u6cd5\u306e\u8ab2\u984c. \u65e5\u8001\u533b\u8a8c 2021; 58: 36-40."}],"container-title":["Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/geriatrics\/63\/3\/63_63.237\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:18:42Z","timestamp":1789791522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/geriatrics\/63\/3\/63_63.237\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3143\/geriatrics.63.237","relation":{},"ISSN":["0300-9173"],"issn-type":[{"value":"0300-9173","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"article-number":"63.237"}}